genedrive Signs Sysmex To Distribute Decentralized-Setting HCV Test
Executive Summary
Molecular diagnostics company genedrive has signed a distribution agreement with Sysmex Corporation to distribute its CE-marked HepC (HCV) ID kit and Genedrive platform in the Europe, Middle East and Africa. The Japanese group is the first commercial partner for genedrive's hepatitis C test for decentralized resource-limited settings.
You may also be interested in...
genedrive Severs Ties With India Distributor Xcelris Labs
Molecular diagnostics company genedrive has severed ties with its India distributor Xcleris Labs following problems with its MTB/RIF test for tuberculosis.
genedrive Soon To Launch First Decentralized-Setting HCV Test
The HCV testing paradigm has changed since the advent of direct-acting antiviral drugs. genedrive PLC is looking to capitalize on this growth opportunity with its hepatitis C test, designed for decentralized use in resource-limited settings.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.